Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-09

FDA Approved: CHLORTHALIDONE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the generic chlorthalidone under an original ANDA from Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)

Snippet

ORIG AP for CHLORTHALIDONE (CHLORTHALIDONE)